Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Canexis Pharma
Schlattingen / Basadingen-Schlattingen, Thurgau, Switzerlandcanexis.ch ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Canexis Pharma AG is a Swiss GMP-certified manufacturer specializing in high-purity medical cannabis extracts and active pharmaceutical ingredients, including cannabidiol and dronabinol. The company has received Swissmedic approval for large-scale production, positioning itself as a key supplier for both bespoke prescription medicines and future finished pharmaceuticals. Its facility can process up to 1,000 kg of cannabis per day, producing up to 100 kg of pure product daily. The company emphasizes quality, regulatory compliance, and long-term commitment to the evolving cannabinoid-based pharmaceuticals market
- Therapeutic areas
- NeurologyOther
- Modalities
- Small molecule (for cannabinoids such as cannabidiol and dronabinol)Plant extract
- Industry
- Contract Manufacturing Organization
02
Partnerships
No major pharma/biotech partnerships publicly disclosed; knowledge-sharing with leading U.S. cannabis firms mentioned
Beyond the preview
Go deeper on Canexis Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Canexis Pharma.